Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Getting to the heart of cardiovascular diseases

13.04.2006


A new collaboration covers the spectrum from molecules to therapies



Today three research organisations announce the merging of their expertise to fight cardiovascular diseases, which are among the most common health problems and causes of death in the world. The Magdi Yacoub Institute (MYI) at the UK’s Harefield Heart Science Centre, Imperial College London, and a unit of the European Molecular Biology Laboratory (EMBL) near Rome will work together to connect discoveries in basic research to new therapies and treatments.

“The medicine of the future will link discoveries about genes and the body’s healing mechanisms to prevention and therapies for diseases,” says Nadia Rosenthal, who heads EMBL’s Mouse Biology Unit in Monterotondo. “With the help of our transgenic mouse models for heart disease we can investigate the genes that play a role in the development of heart defects and this knowledge can then form the basis for clinical studies with patients.”


Sir Magdi Yacoub, founder and Director of Research at the Harefield Heart Science Centre funded by the MYI is one of the world’s foremost experts in the fields of organ transplantations and heart research. He established the largest heart and lung transplantation programme in the world at Harefield Hospital. The Heart Science Centre, which is operated collaboratively by the MYI, the Royal Brompton & Harefield Hospital Trust and the National Heart and Lung Institute at Imperial College, already has several research groups devoted to various aspects of heart disease, ranging from molecular and cell biology up to tissue engineering of heart valves. The new collaboration arose from contacts between Yacoub and Rosenthal, who has developed models of heart disease and tissue regeneration in mice.

“Basic and clinical research have traditionally been quite separate, and today there’s still a considerable gap,” Yacoub says. “Pooling the resources and expertise of our complementary institutes in this new collaboration we will bridge this gap. In this way we can obtain the integrated understanding of the cardiovascular system that we need to transfer what we have learned about heart diseases in the laboratory to patients as soon as possible.”

The collaboration will initially run for four years and will formalize joint research projects between the Yacoub and Rosenthal laboratories. One focus will be to study the molecular mechanisms that lead to heart failure, in hopes of finding ways to intervene. Another topic will be to investigate the molecular and cellular basis of new types of therapies, developed at the Heart Science Centre, which have been effective in reversing damage after heart failure. Finally, there will be a focus on heart transplantation and tissue engineering, aiming towards regenerative therapies.

Alongside research, the project will promote mutual education and exchanges of personnel, including a series of interdisciplinary courses and symposia.

The new collaboration builds on the existing strong connections between Imperial College London and EMBL. “This new centre of excellence for biomedical research will strengthen the close relations between the institutes and leads the way for many more collaborations in different research areas”, says Professor Stephen Smith, Principal of the Faculty of Medicine at Imperial College London.

Anna-Lynn Wegener | alfa
Further information:
http://www.embl.de
http://www.embl.org/aboutus/news/press/2006/10apr06/index.html

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>